B+
Bull case
20%
Probability
Target price
$9.00
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
IMRX
ImmuneeringCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
The Q2 update preserved the core thesis: encouraging Phase 2a pancreatic-cancer data, active dosing in a pivotal Phase 3 program, and runway into 2029. [#PR-EARNINGS-2026-08-05]
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +13.3.
What can break
Low coverage leaves no verified consensus surprise, estimate revision, target revision, or trusted post-print market-reaction signal.
Momentum
44
Value
41
Sentiment
71
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.75 · Bull $9.00 · Bear $2.75Analysis 2026-08-17; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-17 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $17.17
Why
Momentum44 · Δ7d -43.1
Value41 · Δ7d -0.0
Sentiment71 · Δ7d +13.3
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +13.3.
Contradictions & invalidation
- • Low coverage leaves no verified consensus surprise, estimate revision, target revision, or trusted post-print market-reaction signal.
- • MAPKeeper 301 enrollment and execution could take longer than expected; no efficacy readout is available yet.
- • The evidence remains pre-readout and the strongest clinical signal comes from a small single-arm study.
Catalyst clock
2026-11-15
MAPKeeper 301 Phase 3 execution is now underway
Lead driver: Sentiment · See AI snapshot
Momentum
44
9% active weight
Current posture
7d trendSoftening
Δ7d
-43.1
Δ21d
+18.5
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
71
62% active weight
Current posture
7d trendImproving
Δ7d
+13.3
Δ21d
+17.3
Why this grade
Composite grade C. Momentum 44.3 / Value 41.2 / Sentiment 70.9
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-17. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$4.75
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$2.75
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$337.72M
Beta
0.47
Shares Out
64.7M
P/E (TTM) · Derived
-4.1
P/S (TTM)
-
P/FCF (TTM) · Derived
-5.23
Rev YoY
-100.0%
EPS YoY
-33.5%
Gross Margin
-166900.0%
Op Margin
-
Net Debt
-$169.01M
Current Ratio
19.47
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data